The IL-36 receptor may be a new therapeutic target for uncontrolled asthma patients with elevated serum IL-36 levels, as the anti–IL-36R monoclonal antibody can be administered to patients with generalized pustular psoriasis in Japan.39 The gene discussed is IL1RL2; the disease is psoriasis 14, pustular.